Project Management Workshop Carmen B. Jacobs, RN,OCN, CCRP Office of Multicenter Clinical Research.

Slides:



Advertisements
Similar presentations
Implementing the Stroke Palliative Approach Pathway
Advertisements

Investigator Responsibilities in Clinical Research
Essential Documentation GCP Training Seminar 12th October 2011
CROMS NIDCR Clinical Monitoring
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
HOT TOPICS ARCHIVING OR HOW NOT TO DUMP YOUR RUBBISH!
Research Coordination Guidance The Committees on Human Research Serving University of Vermont & Fletcher Allen Health Care
Clinical QA Data Audits A GCP Point of View Linda Del Paggio GCP Compliance BioBridges, LLC.
A Blueprint For Clinical Research: Standard Operating Procedures
Good Clinical Practice in Research
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
Scottish Intercollegiate Guidelines Network (SIGN)
Monitoring and Auditing
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
ROLE OF NURSES IN CLINICAL RESEARCH IN MALAWI OWEN DAIRE BSCN MPH RNM.
CORE COMPETENCIES IN CLINICAL & TRANSLATIONAL RESEARCH: The Child Health Perspective I. Clinical & Translational Research Questions: Extract information.
Knowledge Update Clinical documentation: from preclinical studies to drug registration Split, 12 September 2008.
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
INCLUSION/EXCLUSION CRITERIA 1. The following are considerations when defining the cardiac arrest trial patient population (i.e., the inclusion/exclusion.
Good Clinical Practice GCP
Assessment of Interchangeable Multisource Medicines Quality of BE Data Dr. Henrike Potthast Training workshop: Assessment of Interchangeable.
Overview of the Clinical Trial & Protocol Jane Fendl March 31, 2010
International Human Subject Research Legal and Ethical Considerations for Investigators Theresa J. Colecchia, Esq. Associate General Counsel May 8, 2006.
Feldman 20 February Clinical Trials Design Martha A. Feldman, RAC Drug & Device Development Co., Inc. P.O. Box 3515 Redmond, WA USA
Elements of Clinical Trial Quality Assurance Regulatory Coordinator –SCTR SUCCESS Center QA Monitor – NIDA Clinical Trials Network Stephanie Gentilin,
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
Care Management Going Forward Connie Sixta, RN, PhD, MBA.
Committee Questions Design, Statistical Considerations and Study Conduct 1. There are no clear guidelines regarding the number of people that should be.
Planning and Surviving An Audit/Monitoring visit Carmen B. Jacobs, BS, RN,OCN, CCRP U.T. MD Anderson Cancer Center Houston, Texas U.S.A.
Unanticipated Problems Potentially Involving Risks to Subjects or Others Research Protections Office Serving UVM and FAHC Updated April 2012.
Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
Food Safety Professional Development for Early Childhood Educators Evaluation Plan.
Health Research & Information Division, ESRI, Dublin, July 2008 The Audit Process.
Meeting and Exceeding Language and Communication Mandates Todd Blickenstaff Hablamos Juntos Gisela Prieto Caliente Communications June 2-3, 2003 Cultural.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
The Global Health Network Marijke Geldenhuys 19 September 2014 Adhering to the GCP Principles.. what does that even mean?
Module 3: Informed Consent. This training session contains information regarding: Documenting consent Documenting consent Conducting informed consent.
Building Clinical Infrastructure and Expert Support Michael Steinberg, MD, FACR ULAAC Disparity Project Centinela/Freeman Health System.
Evidence-Based Medicine Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department of.
Step What happens?. Who is responsible? Procedures needed?
Participant Accrual Plans MTN-003 Study-Specific Training.
How to Start An Industry Sponsored Clinical Trial
UNIT-II CLINICAL DATA. UNIT-II CLINICAL DATA: Clinical Data, Application, Challenges, Solutions, Clinical Data Management System.
RIHES JJ: Required Training Version 7.0 Effective Date 27 JAN 2011 Boonlure Pruenglampoo 15 Jan 2014 วันพุธที่ 15 มกราคม พ. ศ 2557 RIHES-JJ Version 7.0.
Ensures that studies are billed for research specific procedures.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
Research Documentation Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic Compliance, Corporate Compliance.
GCP (GOOD CLINICAL PRACTISE)
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Responsibilities of Sponsor, Investigator and Monitor
Good Clinical Practice (GCP) and Monitoring Practices
Recent Evolution of New Drug Review and Approval System in Korea
Responsibilities of Sponsor, Investigator and Monitor
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
Community Participation in Research
Good Clinical Practice
Verification Guidelines for Children with Disabilities
Dramatic Change in Data Review Handling with Analytical Tools
Quality Control SOP 3.12 Release Date: 08/10/2015.
Gilbert Ogetii KEMRI-Wellcome Trust Research Programme Kilifi, Kenya
رضا دادآفرین - مهرماه 1390.
Ethics in Evaluation Research & IRB
Good Clinical Practice in Research
Clinical Research Association TURKEY
Chapter 18 Evaluator.
Protocol Approval Criteria
Presentation transcript:

Project Management Workshop Carmen B. Jacobs, RN,OCN, CCRP Office of Multicenter Clinical Research

Outline Enrollment Source Data Collection Data Management Standard Operating Procedures (SOPs) Quality Assurance Follow-up

Enrollment  General Considerations:  Know the patient population  Support system  Family, friends  Barriers  Socio-Economic  Language  Knowledge deficit  Culture  Transportation  Resources

Enrollment  General Considerations:  Know yourself  Barriers  Language  Knowledge deficit  Culture  Pre-conceived ideas regarding the protocol (e.g. phase 1 studies versus phase 3)

Enrollment  General Considerations:  Know the disease  Know the protocol  Eligibility criteria  Know community resources, outreach groups  Multidisciplinary team

Source Data Collection All clinical trial information should be recorded, handled, and stored in a way that allows its accurate reporting, interpretation and verification. -ICH Topic E6(R) Guidelines for Good Clinical Practice Section 2.10

Essential Documents – Documents that individually and collectively permit the evaluation of the conduct of a trial and the quality of data produced. Source Documents – Original records that substantiate the existence of clinical trial subjects

Data Management  General Considerations:

Standard Operating Procedures (SOPs)  General Considerations:

Follow-Up  General Considerations:

wisdom after “There is no wisdom equal to that which comes after the event.” - Geraldine Jewsbury